HiBFF Announces Launch of V2.0 AI Companionship Platform with Integrated Ethical Safety Architecture

HiBFF announced the deployment of HiBFF V2.0, an artificial intelligence companionship platform developed to address ...

Regentis Expanding Pivotal Phase III GelrinC Clinical Site Network: Adding Several Leading Orthopedic Centers Across the U.S.

New sites expected to further accelerate patient enrollment, which surpassed 50% in Phase III study, as well as support ...

AgomAb Therapeutics NV Readies US IPO On Early Promising Results

AgomAb Therapeutics NV ( AGMB) has filed to raise $200 million in development capital in an IPO of its American Depositary Shares representing underlying common shares, according to SEC F-1/A ...
Hospital News

HHS Centre for Burn Research leads national trial for scar treatment

Stay informed on Burn Research advancements at Hamilton Health Sciences and their innovative trial for better burn recovery ...

Regentis Biomaterials Ltd: Regentis Expanding Pivotal Phase III GelrinC Clinical Site Network: Adding Several Leading Orthopedic Centers Across the U.S.

New sites expected to further accelerate patient enrollment, which surpassed 50% in Phase III study, as well as support future clinical programsGelrinC is set to transform cartilage repair market with ...

Ainnocence and Phase Advance Enter Industry-First AI Collab to Reduce Drug Development Timeline and Clinical Trial Risk

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...
Opinion
C&ENOpinion

US vaccine guidance was evidence based—until now

The Evidence to Recommendations framework ensured that the US vaccine schedule was scientifically sound. Then RFK Jr. abandoned it ...